Excited to share our latest work published in JACC Advances! In this study, we explore the role of transfer status in cardiogenic shock pts receiving Impella support, with interesting findings-no higher mortality, but differences in complications & resource use, so do give a read
Excited to share our latest work published in JACC Advances! In this study, we explore the role of transfer status in cardiogenic shock pts receiving Impella support, with interesting findings-no higher mortality, but differences in complications & resource use, so do give a read
📚 The latest work from Onvida Health @OnvidaHealth by Dr. Kameel Kassab and their team is now featured in RCM!
Welcome to read this article 👉:
https://t.co/H8inzZKkfN
Article Highlights
💡 How can TAVR be safely and effectively applied in patient populations underrepresented in clinical trials?
This review examines current evidence on TAVR in special populations, including patients with active malignancies, psychiatric disorders, and advanced organ dysfunction.
✒️ Author: Kameel Kassab, Karnav Modi @KarnavModi , Christian Torres,
Talal Asif
🏪 Affiliation: Onvida Health @OnvidaHealth ; University of Missouri
📖 Don’t miss this citable reference for your future research!
Citation format: Kameel Kassab, Karnav Modi, Christian Torres, Talal Asif. Transcatheter Aortic Valve Replacement in Special Population Groups. Rev. Cardiovasc. Med. 2025, 26(11), 45993.
Welcome to submit your work via our submission link👉: https://t.co/t3hP2jZTf9
RCM welcomes review papers, research articles and other types of research in both cardiovascular medicine and cardiovascular disease.
📖 Click here for author guidelines: https://t.co/tKLwCKyDww
#TAVR #Cardiology #HeartValve #ClinicalResearch #RCMPaper
Thrilled to present our work, “Comparative Outcomes and Trends of Percutaneous Carotid Artery Revascularization vs Carotid Endarterectomy,” at #TCT2025 in SFO!
A truly inspiring conference filled with incredible learning, meaningful conversations, and wonderful memories.
🚨Hot off the press 🚨
A lesser-known vulnerability in CAR T-cell therapy: Sarcopenia.
New in CCR @AACR
Predicts ↑ NRM
1/3 patients lose >10% muscle by D30
Linked to fatty acid catabolism
With @MichaelDJain@KRejeski@MSubklewe@DrFredLocke
https://t.co/EDNgDAS1QP
Excited to celebrate the outstanding fellowship match results of our UMKC Internal Medicine residents! We’re proud of your achievements and look forward to your continued success in the next chapter of your careers. #UMKCIM#FellowshipMatch2024